Dynavax宣布獲得歐盟委員會授權的HEPLISAVB®（2劑量成人乙型肝

StephenW

Dynavax Announces European Commission Marketing Authorization for HEPLISAV B®, a 2 Dose Adult Hepatitis B Adjuvanted Vaccine

-- Approval follows positive opinion by European Committee for Medicinal Products for Human Use

-- Approval based on safety and immunogenicity results from three Phase 3 clinical trials

-- Statistically significantly higher and faster rates of protection and similar safety compared to Engerix-B in all 3 trials

-- HEPLISAV B is the only 2-dose adult hepatitis B vaccine offering protection in just 1 month
Dynavax宣布獲得歐盟委員會授權的HEPLISAVB®（2劑量成人乙型肝炎佐劑疫苗）的市場營銷授權

-批准遵循歐洲人用藥用產品委員會的積極意見

-基於三項3期臨床試驗的安全性和免疫原性結果批准

-在所有3個試驗中，與Engerix-B相比，統計學上明顯更高，更快的保護率和相似的安全性

-HEPLISAV B是唯一可在短短1個月內提供保護的2劑量成人乙型肝炎疫苗
https://www.prnewswire.com/news- ... cine-301231803.html

lancas

可惜不是治疗疫苗~~~